US Patent 7030149 Combination of brimonidine timolol for topical ophthalmic use
Patent 7030149 was granted and assigned to Allergan, Inc. on April, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 Nov, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+305 characters)
Article
Patent abstract
Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Amy L. Batoosingh0
Chin-Ming Chang0
Cynthia C. Pratt0
Gary J. Beck0
Date of Patent
April 18, 2006
0Patent Application Number
101267900
Date Filed
April 19, 2002
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7030149 Combination of brimonidine timolol for topical ophthalmic use
Find more entities like US Patent 7030149 Combination of brimonidine timolol for topical ophthalmic use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
